Ng Kheng-Seong, Nassar Natasha, Soares Deanne, Stewart Patrick, Gladman Marc A
Academic Colorectal Unit, Sydney Medical School, University of Sydney, Hospital Road, Concord, NSW, Australia.
Menzies Centre for Health Policy, School of Public Health, University of Sydney, Sydney, Australia.
Int J Colorectal Dis. 2017 Sep;32(9):1327-1335. doi: 10.1007/s00384-017-2844-2. Epub 2017 Jul 15.
Outcomes of acute lower gastrointestinal haemorrhage (ALGIH) are mostly derived from studies performed in the sub-acute/elective rather than the emergency department (ED) setting. The aims of this study were to determine the incidence and outcomes of patients presenting to a tertiary hospital ED with ALGIH and to identify associated clinicopathological risk factors.
A retrospective observational cohort study of consecutive patients presenting with ALGIH to a tertiary hospital ED was performed. Primary outcome measures included mortality and hospital (including high dependency [HDU]) admission. Secondary outcome measures included rates of (i) blood transfusion, (ii) radiological/endoscopic investigation(s) and (iii) therapeutic intervention.
ALGIH accounted for 949 (512 M, mean age 62.3 years) of 130,262 (0.73%) ED presentations, of which 285 patients (30.1%) were on anti-platelet/coagulant therapy. There were five deaths (0.5%). Hospital admission was required in 498 patients (52.5%), of which 19 (3.8%) required HDU monitoring. Hospital admission was twice as likely in males and four times more likely in patients >75 years old and those taking multiple anti-platelet/coagulant therapy (P < 0.05). Blood product transfusion was required in 172 patients (34.5%), specialist investigations in 230 (46.2%) and therapeutic intervention in 51 (10.2%) (surgery in 24 [4.8%]; endoscopic haemostasis in 20 [4.0%] and angiographic embolisation in 9 [1.8%] patients).
ALGIH accounts for 1% of all ED presentations, with half requiring hospital admission. Mortality and surgical intervention rates are low and although most patients can be managed supportively, access to interventional radiology/endoscopy is important.
急性下消化道出血(ALGIH)的研究结果大多来自亚急性/择期而非急诊科(ED)环境下开展的研究。本研究的目的是确定三级医院急诊科收治的ALGIH患者的发病率和结局,并识别相关的临床病理风险因素。
对一家三级医院急诊科连续收治的ALGIH患者进行回顾性观察队列研究。主要结局指标包括死亡率和住院(包括高依赖病房[HDU])情况。次要结局指标包括:(i)输血率,(ii)影像学/内镜检查率,以及(iii)治疗干预率。
在130262例急诊科就诊患者中,ALGIH占949例(512例男性,平均年龄62.3岁),占0.73%,其中285例患者(30.1%)正在接受抗血小板/抗凝治疗。有5例死亡(0.5%)。498例患者(52.5%)需要住院,其中19例(3.8%)需要HDU监测。男性住院的可能性是女性的两倍,75岁以上患者以及接受多种抗血小板/抗凝治疗的患者住院的可能性是其他患者的四倍(P<0.05)。172例患者(34.5%)需要输血,230例(46.2%)需要专科检查,51例(10.2%)需要治疗干预(24例[4.8%]接受手术;20例[4.0%]接受内镜止血,9例[1.8%]接受血管造影栓塞)。
ALGIH占所有急诊科就诊病例的1%,其中一半需要住院。死亡率和手术干预率较低,尽管大多数患者可以通过支持治疗进行管理,但介入放射学/内镜检查的可及性很重要。